000 01408 a2200409 4500
005 20250515025359.0
264 0 _c20060810
008 200608s 0 0 eng d
022 _a0271-0749
024 7 _a10.1097/01.jcp.0000219926.49799.89
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrebs, Michael
245 0 0 _aLevetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cJun 2006
300 _a347-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter
650 0 4 _aAdult
650 0 4 _aAlcoholism
_xcomplications
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevetiracetam
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNootropic Agents
_xtherapeutic use
650 0 4 _aPilot Projects
650 0 4 _aPiracetam
_xanalogs & derivatives
650 0 4 _aSubstance Withdrawal Syndrome
_xdrug therapy
700 1 _aLeopold, Karolina
700 1 _aRichter, Christoph
700 1 _aKienast, Thorsten
700 1 _aHinzpeter, Axel
700 1 _aHeinz, Andreas
700 1 _aSchaefer, Martin
773 0 _tJournal of clinical psychopharmacology
_gvol. 26
_gno. 3
_gp. 347-9
856 4 0 _uhttps://doi.org/10.1097/01.jcp.0000219926.49799.89
_zAvailable from publisher's website
999 _c16302612
_d16302612